Screening for pre-eclampsia; exploring women's views
Research type
Research Study
Full title
A qualitative study to explore the views and opinions of women with diabetes about pre-eclampsia and screening tests for pre-eclampsia
IRAS ID
149916
Contact name
Valerie Holmes
Contact email
Sponsor organisation
Queen's University Belfast
Research summary
Pre-eclampsia effects between 2% and 5% of pregnancies in the developing world each year. It is defined as sudden onset hypertension and extensive proteinuria and it can lead to the development of other serious conditions, such a eclampsia. It is one of the leading causes of maternal and neonatal mortality and there is currently no effective treatment available to women. There are a number of risk factors for the disease including type 1 diabetes mellitus. Women with type 1 diabetes are at a two to four fold increase in developing pre-eclampsia. There has been a considerable amount of research conducted into developing a predictive screening test, with the use of biomarkers and biophysical measures. However, there is considerable lack of research in terms of assessing the opinion of women about the implementation of such a test. Through the use of semi-structured interviews, this study aims to explore the views and opinions of women with type 1 diabetes in relation to pre-eclampsia and the implementation of a possible screening test for pre-eclampsia.
REC name
South West - Cornwall & Plymouth Research Ethics Committee
REC reference
14/SW/1015
Date of REC Opinion
1 Jul 2014
REC opinion
Further Information Favourable Opinion